Abstract
Childhood cancer survivors are at increased risk for treatment-related late effects; data are lacking on how coronavirus disease 2019 (COVID-19) infection impacts this cohort. We assessed COVID-19-related symptoms, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG seroprevalence, and rate of COVID-19-related hospitalization among 321 asymptomatic survivors of childhood cancer or transplantation seen for routine long-term follow-up between May and September 2020 in a New York City tertiary cancer center. While 10.9% (n = 35) reported possible COVID-19-related symptoms, 7.8% (n = 20) of those tested had positive SARS-CoV-2 IgG, and one patient (0.3%) required COVID-19-related hospitalization. This report suggests that childhood cancer survivors appear to be at relatively low risk for COVID-19 complications.
Keywords: COVID-19; SARS-CoV-2; childhood cancer; survivors.
【저자키워드】 COVID-19, SARS-CoV-2, Survivors, childhood cancer, 【초록키워드】 coronavirus disease, IgG, coronavirus, Hospitalization, Cancer, Infection, risk, New York City, COVID-19 complications, Cohort, Survivors, Asymptomatic, Impact, Patient, childhood, SARS-CoV-2 IgG, Long-term follow-up, Cancer center, acute respiratory syndrome, increased risk, positive, COVID-19-related symptoms, while, survivor, tested, reported, required, 【제목키워드】 pediatric, Cancer, New York City, childhood, cell transplantation, single center, survivor,